Transitions from injecting to non-injecting drug use: Potential protection against HCV infection

Don Des Jarlais, Courtney Mcknight, Kamyar Arasteh, Jonathan Feelemyer, David C. Perlman, Holly Hagan, Hannah L F Cooper

Research output: Contribution to journalArticle

Abstract

Transitions from injecting to non-injecting drug use have been reported from many different areas, particularly in areas with large human immunodeficiency virus (HIV) epidemics. The extent to which such transitions actually protect against HIV and HCV has not been determined. A cross-sectional survey with HIV and hepatitis C (HCV) testing was conducted with 322 former injectors (persons who had injected illicit drugs but permanently transitioned to non-injecting use) and 801 current injectors recruited in New York City between 2007 and 2012. There were no differences in HIV prevalence, while HCV prevalence was significantly lower among former injectors compared to current injectors. Years injecting functioned as a mediating variable linking former injector status to lower HCV prevalence. Transitions have continued well beyond the reduction in the threat of AIDS to injectors in the city. New interventions to support transitions to non-injecting drug use should be developed and supported by both drug treatment and syringe exchange programs.

Original languageEnglish (US)
Pages (from-to)325-331
Number of pages7
JournalJournal of Substance Abuse Treatment
Volume46
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

HIV
Infection
Pharmaceutical Preparations
Needle-Exchange Programs
Street Drugs
Hepatitis C
Acquired Immunodeficiency Syndrome
Cross-Sectional Studies

Keywords

  • Drug use
  • HCV
  • HIV
  • Injecting drug use
  • Non-injecting drug use
  • Substance abuse

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Phychiatric Mental Health
  • Medicine (miscellaneous)

Cite this

Transitions from injecting to non-injecting drug use : Potential protection against HCV infection. / Des Jarlais, Don; Mcknight, Courtney; Arasteh, Kamyar; Feelemyer, Jonathan; Perlman, David C.; Hagan, Holly; Cooper, Hannah L F.

In: Journal of Substance Abuse Treatment, Vol. 46, No. 3, 03.2014, p. 325-331.

Research output: Contribution to journalArticle

@article{a1dd54bea769428587ef27c2d8bcee77,
title = "Transitions from injecting to non-injecting drug use: Potential protection against HCV infection",
abstract = "Transitions from injecting to non-injecting drug use have been reported from many different areas, particularly in areas with large human immunodeficiency virus (HIV) epidemics. The extent to which such transitions actually protect against HIV and HCV has not been determined. A cross-sectional survey with HIV and hepatitis C (HCV) testing was conducted with 322 former injectors (persons who had injected illicit drugs but permanently transitioned to non-injecting use) and 801 current injectors recruited in New York City between 2007 and 2012. There were no differences in HIV prevalence, while HCV prevalence was significantly lower among former injectors compared to current injectors. Years injecting functioned as a mediating variable linking former injector status to lower HCV prevalence. Transitions have continued well beyond the reduction in the threat of AIDS to injectors in the city. New interventions to support transitions to non-injecting drug use should be developed and supported by both drug treatment and syringe exchange programs.",
keywords = "Drug use, HCV, HIV, Injecting drug use, Non-injecting drug use, Substance abuse",
author = "{Des Jarlais}, Don and Courtney Mcknight and Kamyar Arasteh and Jonathan Feelemyer and Perlman, {David C.} and Holly Hagan and Cooper, {Hannah L F}",
year = "2014",
month = "3",
doi = "10.1016/j.jsat.2013.09.004",
language = "English (US)",
volume = "46",
pages = "325--331",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Transitions from injecting to non-injecting drug use

T2 - Potential protection against HCV infection

AU - Des Jarlais, Don

AU - Mcknight, Courtney

AU - Arasteh, Kamyar

AU - Feelemyer, Jonathan

AU - Perlman, David C.

AU - Hagan, Holly

AU - Cooper, Hannah L F

PY - 2014/3

Y1 - 2014/3

N2 - Transitions from injecting to non-injecting drug use have been reported from many different areas, particularly in areas with large human immunodeficiency virus (HIV) epidemics. The extent to which such transitions actually protect against HIV and HCV has not been determined. A cross-sectional survey with HIV and hepatitis C (HCV) testing was conducted with 322 former injectors (persons who had injected illicit drugs but permanently transitioned to non-injecting use) and 801 current injectors recruited in New York City between 2007 and 2012. There were no differences in HIV prevalence, while HCV prevalence was significantly lower among former injectors compared to current injectors. Years injecting functioned as a mediating variable linking former injector status to lower HCV prevalence. Transitions have continued well beyond the reduction in the threat of AIDS to injectors in the city. New interventions to support transitions to non-injecting drug use should be developed and supported by both drug treatment and syringe exchange programs.

AB - Transitions from injecting to non-injecting drug use have been reported from many different areas, particularly in areas with large human immunodeficiency virus (HIV) epidemics. The extent to which such transitions actually protect against HIV and HCV has not been determined. A cross-sectional survey with HIV and hepatitis C (HCV) testing was conducted with 322 former injectors (persons who had injected illicit drugs but permanently transitioned to non-injecting use) and 801 current injectors recruited in New York City between 2007 and 2012. There were no differences in HIV prevalence, while HCV prevalence was significantly lower among former injectors compared to current injectors. Years injecting functioned as a mediating variable linking former injector status to lower HCV prevalence. Transitions have continued well beyond the reduction in the threat of AIDS to injectors in the city. New interventions to support transitions to non-injecting drug use should be developed and supported by both drug treatment and syringe exchange programs.

KW - Drug use

KW - HCV

KW - HIV

KW - Injecting drug use

KW - Non-injecting drug use

KW - Substance abuse

UR - http://www.scopus.com/inward/record.url?scp=84892476108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892476108&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2013.09.004

DO - 10.1016/j.jsat.2013.09.004

M3 - Article

C2 - 24161262

AN - SCOPUS:84892476108

VL - 46

SP - 325

EP - 331

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 3

ER -